People of color may be less familiar with the different treatment rates with biologic therapies for psoriasis and are more likely to be hospitalized for psoriasis compared with white patients with psoriasis, according to a review published in Dermatology and Therapy.
Geetav Yadav and colleagues conducted a targeted literature review to identify studies describing unmet needs in people with psoriasis and People of color in Canada and the US, specifically regarding challenges associated with access to care, diagnosis, or treatment. The review focused on studies of psoriasis published in the last five years (January 1, 2016–October 19, 2021). After screening 919 unique records, 26 studies were included in the study.
The researchers found from the data captured in this review that healthcare is less accessible for people of color with psoriasis than for white individuals. In addition, studies revealed that for psoriasis, in particular, access to general care and specialist physicians may differ among people of color.
According to the findings, the clinical presentation of psoriasis can differ across racial/ethnic groups, which may hinder diagnosis. In addition, people of color may have different rates of treatment with biologic therapies for psoriasis and may be more likely to be hospitalized for psoriasis than white individuals.
The researchers found that in Canada and the United States, barriers to seeking competent care for people of color with psoriasis include the cost of care and cultural views about psoriasis.
Furthermore, it was found that people of color are underrepresented in clinical trials of psoriasis therapies. In a systematic review of six hundred and twenty-six randomized control trials for dermatologic conditions, including psoriasis (2010–2015), 74.4% of all trial participants were white. In addition to underrepresentation, clinical trial findings for dermatological disorders like plaque psoriasis lack thorough racial/ethnic data, to treat this you should try choose the best one (cream for this).
“It is crucial that dermatologists and other stakeholders in the healthcare system recognize and act on health disparities affecting people with psoriasis and SoC to ensure equitable care.” the researchers wrote. “Further, it is essential to address the poor representation of patients with brown and black skin in mainstream dermatology textbooks and atlases, and promote education within SoC communities regarding the recognition of psoriasis and the safety and efficacy of current treatments, to decrease unmet needs.”
Source: Dermatology and Therapy.